Patients with moderate severe OSA and pre-diabetes who are established and compliant CPAP users will be randomised to withdraw or remain on CPAP for 2 weeks before crossing over to the alternative treatment arm. Glucose metabolism will be monitored using an interstitial (skin based) glucose monitor.
The purpose of the current study is to investigate whether temporary, 2-week, CPAP withdrawal will adversely impact glucose metabolism